Grupo Biotoscana
Founded Year
1987Stage
Acq - P2P | AcquiredValuation
$0000About Grupo Biotoscana
Grupo Biotoscana (GBIO33) is a pharmaceutical multinational company, provides pharma, biological, hospital, oncological, and generic products.On November 29th, 2019, Grupo Biotoscana was acquired by Knight Therapeutics.3M.
Grupo Biotoscana Headquarter Location
Dr Luis Bonavita 1294, #2004
Montevideo, 11300,
Uruguay
+598 2626 2344
Expert Collections containing Grupo Biotoscana
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Grupo Biotoscana is included in 1 Expert Collection, including Cancer.
Cancer
1,179 items
Pharmaceutical and biotechnology companies with cancer therapy drug candidates.
Latest Grupo Biotoscana News
Sep 21, 2020
Davies Ward Phillips & Vineberg, Pinheiro Neto, Bonn Steichen & Partners and Lobo de Rizzo advised on the transaction Knight Therapeutics Inc. (TSX: GUD) and its wholly owned subsidiary 1178991 CANADA INC. completed the tender offer process filed by 1178991 CANADA INC. for the acquisition and delisting of all outstanding Brazilian Depositary Receipts of Biotoscana Investments S.A. Knight Therapeutics Inc., headquartered in Montreal, Canada, is a pan-American (ex-US) specialty pharmaceutical company focused on developing, acquiring or in-licensing and commercializing innovative pharmaceutical products for Canada and Latin America. Knight owns a controlling stake in Grupo Biotoscana, a pan-Latin American specialty pharmaceutical company. Davies Ward Phillips & Vineberg advised Knight Therapeutics Inc. with Hillel W. Rosen (Picture), Brian Kujavsky, Shayna Goldman and Julia Knafo. In Brazil, Pinheiro Neto advised Knight Therapeutics Inc. with Guilherme Sampaio Monteiro, Milena Casado de Oliveira, Marcelo Junqueira de Mello, Taisa Sani and Letícia Fonseca Marcondes Venancio. In Brazil, Lobo de Rizzo Advogados advised Advent International and Essex Woodlands
When was Grupo Biotoscana founded?
Grupo Biotoscana was founded in 1987.
Where is Grupo Biotoscana's headquarters?
Grupo Biotoscana's headquarters is located at Dr Luis Bonavita 1294, #2004, Montevideo.
What is Grupo Biotoscana's latest funding round?
Grupo Biotoscana's latest funding round is Acq - P2P.
Who are the investors of Grupo Biotoscana?
Investors of Grupo Biotoscana include Knight Therapeutics.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.